{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorders&page=8", "query": { "condition": "Skin Disorders", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 16107, "total_pages": 1611, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorders&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Disorders&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T17:26:42.887Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02037347", "title": "Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Toxic Epidermal Necrolysis", "Stevens-Johnson Syndrome" ], "interventions": [ { "name": "Palifermin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brett King", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2010-10", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-11-30", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 2, "location_summary": "Bridgeport, Connecticut • New Haven, Connecticut", "locations": [ { "city": "Bridgeport", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02037347" }, { "nct_id": "NCT04557449", "title": "Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Liposarcoma", "Prostate Cancer", "Advanced Breast Cancer", "NSCLC (Non-small Cell Lung Cancer)", "Colorectal Cancer" ], "interventions": [ { "name": "PF-07220060", "type": "DRUG" }, { "name": "Letrozole", "type": "COMBINATION_PRODUCT" }, { "name": "Fulvestrant", "type": "COMBINATION_PRODUCT" }, { "name": "Midazolam", "type": "OTHER" }, { "name": "Enzalutamide", "type": "COMBINATION_PRODUCT" }, { "name": "Giredestrant", "type": "COMBINATION_PRODUCT" }, { "name": "Tamoxifen", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 430, "start_date": "2020-09-23", "completion_date": "2029-10-07", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 14, "location_summary": "Los Angeles, California • New Haven, Connecticut • Trumbull, Connecticut + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04557449" }, { "nct_id": "NCT07227649", "title": "NAC-REPAIR for Post-surgical Pain", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carpal Tunnel Surgery", "Trigger Finger Disorder", "De Quervain Syndrome", "Guyon's Canal", "Dupuytren Contracture", "Morton Neuroma", "Tarsal Tunnel Syndrome", "Plantar Fasciopathy", "Peroneal Nerve Entrapment" ], "interventions": [ { "name": "NAC", "type": "DRUG" }, { "name": "NAC 0mg/day (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2026-10-15", "completion_date": "2027-07-15", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227649" }, { "nct_id": "NCT06230185", "title": "CtDNA Based MRD Testing for NAC Monitoring in TNBC", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "TNBC - Triple-Negative Breast Cancer", "Minimal Residual Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Personalis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 422, "start_date": "2023-11-09", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2025-01-07", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 14, "location_summary": "Tucson, Arizona • Aurora, Colorado • Washington D.C., District of Columbia + 11 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06230185" }, { "nct_id": "NCT02915835", "title": "Riociguat in Scleroderma Associated Digital Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scleroderma", "Digital Ulcers" ], "interventions": [ { "name": "Riociguat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dinesh Khanna, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2016-09", "completion_date": "2018-07-24", "has_results": true, "last_update_posted_date": "2019-09-24", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 5, "location_summary": "Washington D.C., District of Columbia • Ann Arbor, Michigan • New York, New York + 2 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02915835" }, { "nct_id": "NCT00627276", "title": "Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Precancerous Condition" ], "interventions": [ { "name": "omega-3 fatty acid", "type": "DIETARY_SUPPLEMENT" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "21 Years to 120 Years · Female only" }, "enrollment_count": 16, "start_date": "2007-12", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2017-04-27", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 2, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00627276" }, { "nct_id": "NCT03307044", "title": "Fractional CO2 Laser Therapy for Survivors of Breast Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma", "Cancer Survivor", "Cervical Carcinoma", "Dyspareunia", "Vaginal Dryness" ], "interventions": [ { "name": "Laser Therapy", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 66, "start_date": "2017-11-16", "completion_date": "2022-05-05", "has_results": false, "last_update_posted_date": "2023-03-20", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03307044" }, { "nct_id": "NCT04913064", "title": "Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma" ], "interventions": [ { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "White Button Mushroom Extract", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 26, "start_date": "2021-07-27", "completion_date": "2027-01-12", "has_results": false, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04913064" }, { "nct_id": "NCT02296632", "title": "Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Arthritis, Rheumatoid", "Medication Adherence" ], "interventions": [ { "name": "Motion sensors and daily online assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 7, "start_date": "2014-11", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-08-19", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02296632" }, { "nct_id": "NCT07137598", "title": "A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Afimkibart", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2025-12-05", "completion_date": "2027-10-02", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-10-26T17:26:42.887Z", "location_count": 18, "location_summary": "Avondale, Arizona • Peoria, Arizona • La Jolla, California + 15 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07137598" } ] }